Alice M Brinkman

Title: The Innovative Contributions of Alice M Brinkman

Introduction

Alice M Brinkman is a notable inventor based in Tustin, California. She has made significant contributions to the field of biotechnology, particularly in the development of vaccines and immunological responses. With a total of 5 patents to her name, her work has had a profound impact on the understanding and treatment of flavivirus infections.

Latest Patents

Among her latest patents is a recombinant dengue virus antigen that comprises the capsid protein leader sequence, full-length prM protein, and full-length E protein. This invention provides polynucleotides and polypeptides that have advantageous properties, including the ability to induce an immune response to flaviviruses. The polypeptides and polynucleotides of this invention are useful in methods aimed at inducing immune responses against flaviviruses, including dengue viruses. Another significant patent involves polypeptides and virus-like particles that can also induce an immune response to flaviviruses, incorporating sequences such as C15, prM, and E polypeptide sequences.

Career Highlights

Alice has worked with several prominent companies in the biotechnology sector, including Altravax, Inc. and Maxygen, Inc. Her experience in these organizations has allowed her to collaborate on groundbreaking research and development projects that advance the field of immunology.

Collaborations

Alice has collaborated with notable professionals in her field, including Doris Apt and Juha Punnonen. These collaborations have contributed to her innovative research and the successful development of her patents.

Conclusion

Alice M Brinkman is a distinguished inventor whose work in biotechnology has led to significant advancements in vaccine development and immune response mechanisms. Her contributions continue to influence the field and pave the way for future innovations.